Compare ON Semiconductor (ON) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

ON SemiconductorTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

ON Semiconductor vs State Street SPDR S&P Biotech ETF — how do they compare? ON Semiconductor trades at $70.75 (market cap $27.67B), while State Street SPDR S&P Biotech ETF trades at $159.94. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, ON Semiconductor nearer its low. Which is the better fit depends on your goals.

	ON	XBI
Market Cap	$27.67B	—
Sector	Technology	Broad Market / Factor
52-Week High	$133.93	$169.55
52-Week Low	$44.90	$93.43
Enterprise Value	$28.29B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ON Semiconductor

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $161.97, down 1.12% today, with technical indicators showing mixed signals amid a bearish overall trend. The ETF holds over 150 biotech companies and has rallied 76% in the past year, driven by M&A activity and positive clinical trial catalysts. Analyst coverage remains limited with a single hold rating, while recent news highlights sector optimism around cancer vaccine breakthroughs and improved capital access.

Outlook remains cautiously optimistic with potential for 8-14% returns over 6-12 months, though high volatility and regulatory risks persist. Key opportunities include ongoing pharmaceutical M&A and innovation in immunotherapy, while risks center on sector-specific volatility and policy uncertainty.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

On Semiconductor poised for growth with $213B TAM upgrade and Synaptics acquisition ahead of Investor Day 2026Seeking Alpha · 1 day agoBullish ON Semiconductor upgraded to Buy on strong data center growth and new product wins.Seeking Alpha · 1 day agoBullish View details →

XBI

Biotech ETF IBB outperformed S&P 500 by 22 points in 3 months amid pharma patent cliff deals.24/7 Wall Street · 2 days agoBullish State Street SPDR S&P Biotech ETF (XBI) rated Buy with 8%-14% returns expected despite prior 76% rallySeeking Alpha · 4 days agoBullish View details →

About ON Semiconductor

Onsemi develops power and sensing semiconductors for automotive, industrial, and energy applications. Its products support functions such as electric vehicle systems, energy conversion, automation, and intelligent sensing.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.